Indies Pharma Jamaica Limited (JMSE:INDIES)

Indies Pharma Jamaica Revenue

In the fiscal year ending October 31, 2025, Indies Pharma Jamaica had annual revenue of 1.13B JMD, down -2.82%. Indies Pharma Jamaica had revenue of 270.43M in the quarter ending October 31, 2025, a decrease of -7.30%.

• Revenue: 1.13B
• Revenue Growth: -2.82%
• P/S Ratio: 3.35
• Revenue / Employee: 17.60M
• Employees: 64
• Market Cap: 3.77B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2025	1.13B	-32.65M	-2.82%
Oct 31, 2024	1.16B	103.52M	9.81%
Oct 31, 2023	1.06B	118.18M	12.61%
Oct 31, 2022	937.28M	90.45M	10.68%
Oct 31, 2021	846.83M	80.88M	10.56%